More than 2.5 million bottles of a prescription eye medication are being recalled across the United States. The Food and Drug Administration (FDA) raised concerns after finding foreign material in some bottles.
Lupin Pharmaceuticals Inc. recalled 2,530,182 bottles of prednisolone acetate ophthalmic suspension, a type of eye drop. This suspension treats inflammation after eye surgery and helps with certain eye injuries. The bottles were made in Pithampur, India, and sold in different sizes: 5 mL, 10 mL, and 15 mL.
On June 30, the FDA labelled this recall as a Class II recall. This means that using the product could lead to temporary health issues, but serious injuries are unlikely. The affected products have expiration dates from July 2026 to October 2026.
People who have these eye drops should check with their healthcare provider or pharmacist. They can find out if their medication is part of the recall and discuss alternative treatments. Patients should not stop their medication without talking to a healthcare provider first.
Lupin started the recall on June 4 and informed customers by letter. The FDA continues to monitor the situation.
